Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Shares withheld for taxes Chf Scientific Operations Off gave up 4,653 shares (to pay taxes)
  9. 4 Shares withheld for taxes CEO and President gave up 5,069 shares (to pay taxes)
  10. 4 Open-market buy 10% owner bought 50,000 shares at $16.00 ($800,000)
  11. 4 Open-market buy 10% owner bought 300,000 shares at $16.87 ($5,061,000)
  12. 4 Open-market buy Chief Financial Officer bought 1,481 shares at $16.91 ($25,038)
  13. 4 Open-market sale Former 10% Owner sold 2,554 shares at an average $19.40 ($49,541)
  14. 4 Open-market sale 10% owner sold 239 shares at $18.00 ($4,302)
  15. 4 Open-market sale 10% owner sold 13,330 shares at an average $18.73 ($249,632)
  16. 4 Open-market sale 10% owner sold 259 shares at an average $20.58 ($5,331)
  17. 4 Open-market sale 10% owner sold 771 shares at $22.09 ($17,031)
  18. 4 Open-market sale 10% owner sold 2,034 shares at an average $22.39 ($45,543)
  19. 4 Open-market sale 10% owner sold 3,435 shares at an average $22.85 ($78,496)
  20. 4 Open-market sale 10% owner sold 510 shares at $24.18 ($12,333)

Page 9 of 20 · 382 filings